Leadership

Joint Steering Committee

Porter Alliance for Innovative Medicines is governed by a joint steering committee comprising equal representation from Deerfield and Stanford University. Stanford researchers are encouraged to submit proposals for consideration for execution through the collaboration. Accepted proposals will receive a development plan aimed at achieving Investigational New Drug (IND) readiness. Selected proposals will also have the eligibility for additional capital investments to create spin-off companies.

Michele Cleary, Ph.D.

Deerfield JSC Member

Read More

Michael Foley, Ph.D.

Deerfield JSC Member

Read More

Chaitan Khosla, Ph.D.

Stanford JSC Member

Read More

Peter Kim, Ph.D.

Stanford JSC Member

Read More

Sunita Rajdev, Ph.D.

Stanford JSC Member

Read More

William Slattery

Deerfield JSC Member

Read More

Scientific Collaboration Director

Paul Humphries, Ph.D.

Scientific Collaboration Director

Read More